The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arase, H.
Right arrow Articles by Saito, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arase, H.
Right arrow Articles by Saito, T.
The Journal of Immunology, 2001, 166: 21-25.
Copyright © 2001 by The American Association of Immunologists

Negative Regulation of Expression and Function of Fc{gamma}RIII by CD3{zeta} in Murine NK Cells1

Hisashi Arase2, Tadahiro Suenaga, Noriko Arase3, Yoshimitsu Kimura4, Katsuhiko Ito, Ritsuko Shiina, Hiroshi Ohno5 and Takashi Saito6

Department of Molecular Genetics, Chiba University Graduate School of Medicine, Chiba, Japan

Fc{gamma}RIII is involved in Ab-dependent cell-mediated cytotoxicity (ADCC) and cytokine production by NK cells. Signaling and expression of Fc{gamma}RIII are dependent on FcR{gamma}. Although NK cells express not only FcR{gamma} but also CD3{zeta}, the role of CD3{zeta} in NK cell function remains unclear. Here, we found that the expression of Fc{gamma}RIII on NK cells from CD3{zeta}-deficient mice is unexpectedly up-regulated compared with that on cells from normal mice. Furthermore, ADCC and IFN-{gamma} production upon Fc{gamma}RIII-cross-linking by NK cells from CD3{zeta}-deficient mice were also up-regulated. Up-regulation of the surface expression of Fc{gamma}RIII on CD3{zeta}-deficient NK cells is not mediated by transcriptional augmentation of either Fc{gamma}RIII or FcR{gamma} gene because there was no significant difference in the expression of mRNA for Fc{gamma}RIII and FcR{gamma}. Transfection of CD3{zeta} into a cell line expressing Fc{gamma}RIII and FcR{gamma} induced a decrease in the cell surface expression of Fc{gamma}RIII. These findings reveal a negative regulatory role of CD3{zeta} in Fc{gamma}RIII-mediated function of murine NK cells.




This article has been cited by other articles:


Home page
J. Immunol.Home page
K. A. Rogers, F. Scinicariello, and R. Attanasio
IgG Fc Receptor III Homologues in Nonhuman Primate Species: Genetic Characterization and Ligand Interactions
J. Immunol., September 15, 2006; 177(6): 3848 - 3856.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
X. Xie, H. He, M. Colonna, T. Seya, T. Takai, and B. A. Croy
Pathways Participating in Activation of Mouse Uterine Natural Killer Cells During Pregnancy
Biol Reprod, September 1, 2005; 73(3): 510 - 518.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
N. D. Huntington, Y. Xu, S. L. Nutt, and D. M. Tarlinton
A requirement for CD45 distinguishes Ly49D-mediated cytokine and chemokine production from killing in primary natural killer cells
J. Exp. Med., May 2, 2005; 201(9): 1421 - 1433.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Dhanji, K. Tse, and H.-S. Teh
The Low Affinity Fc Receptor for IgG Functions as an Effective Cytolytic Receptor for Self-Specific CD8 T Cells
J. Immunol., February 1, 2005; 174(3): 1253 - 1258.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Y. Setiady, P. Pramoonjago, and K. S. K. Tung
Requirements of NK Cells and Proinflammatory Cytokines in T Cell-Dependent Neonatal Autoimmune Ovarian Disease Triggered by Immune Complex
J. Immunol., July 15, 2004; 173(2): 1051 - 1058.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
I. Shiratori, K. Ogasawara, T. Saito, L. L. Lanier, and H. Arase
Activation of Natural Killer Cells and Dendritic Cells upon Recognition of a Novel CD99-like Ligand by Paired Immunoglobulin-like Type 2 Receptor
J. Exp. Med., February 17, 2004; 199(4): 525 - 533.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Di Gaetano, E. Cittera, R. Nota, A. Vecchi, V. Grieco, E. Scanziani, M. Botto, M. Introna, and J. Golay
Complement Activation Determines the Therapeutic Activity of Rituximab In Vivo
J. Immunol., August 1, 2003; 171(3): 1581 - 1587.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
J. C. Hope, P. Sopp, and C. J. Howard
NK-like CD8+ cells in immunologically naive neonatal calves that respond to dendritic cells infected with Mycobacterium bovis BCG
J. Leukoc. Biol., February 1, 2002; 71(2): 184 - 194.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Arase, T. Saito, J. H. Phillips, and L. L. Lanier
Cutting Edge: The Mouse NK Cell-Associated Antigen Recognized by DX5 Moncoclonal Antibody is CD49b ({alpha}2 Integrin, Very Late Antigen-2)
J. Immunol., August 1, 2001; 167(3): 1141 - 1144.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.